Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - TOTAL CURRENT LIABILITIES
Total Current Liabilities URGN - UroGen Pharma Ltd.
31.2 M
LAST VALUE
18.09%
2 YEAR CAGR
18.31%
5 YEAR CAGR
51.69%
10 YEAR CAGR